Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors
Conference paper
(2018), Annals of oncology
A phase I first-in-human, dose-escalation and expansion study to evaluate the safety and tolerability of NUC-3373 in patients with locally advanced, unresectable or metastatic solid malignancies.
Conference paper
Blagden S. et al, (2018), Ann oncol, 29 Suppl 8
Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours.
Journal article
Lyon PC. et al, (2017), J ther ultrasound, 5
NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.
Journal article
Eyre TA. et al, (2016), Br j haematol, 175, 43 - 54
Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer.
Journal article
Hill EJ. et al, (2016), Clin cancer res, 22, 1922 - 1931
2761 Phase II clinical trial of 6 mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours
Conference paper
Nicum S. et al, (2015), European journal of cancer, 51, S551 - S551
Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndrome.
Journal article
Eyre TA. et al, (2015), Bmc cancer, 15
A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol.
Journal article
Nicum S. et al, (2014), Bmc cancer, 14
Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.
Journal article
Nicum S. et al, (2013), Journal of clinical oncology, 31, TPS5615 - TPS5615